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DObjective: Coronary artery bypass grafting (CABG) with incomplete revascularization (ICR) is thought to
decrease survival. We studied the survival of patients with ICR undergoing total arterial grafting.
Methods: In a consecutive series of all-comer 1000 patients with isolated CABG, operative and midterm sur-
vival were assessed for patients undergoing complete versus ICR, with odds ratios and hazard ratios, adjusted for
European System for Cardiac Operative Risk Evaluation category, CABG urgency, age, and comorbidities.
Results: In this series of 1000 patients with 98% arterial grafts (2922 arterial, 59 vein grafts), 73% of patients
with multivessel disease received bilateral internal mammary artery grafts. ICR occurred in 140 patients (14%).
Operative mortality was 3.8% overall, 8.6% for patients with ICR, and 3.2% for patients with complete revas-
cularization (P ¼ .008). For operative mortality using multivariable logistic regression, after controlling for
European System for Cardiac Operative Risk Evaluation category (P<.001) and CABG urgency (P¼ .03), there
was no evidence of a statistically significant increased risk of death due to ICR (odds ratio, 1.73; 95% confidence
interval, 0.80-3.77). For midterm follow-up (median, 54 months [interquartile range, 27-85 months]), after con-
trolling for European System for Cardiac Operative Risk Evaluation category (P< .001) and comorbidities
(P¼ .017) there was a significant interaction between age 80 years and ICR (P¼ .017) in predicting mortality.
The adjusted hazard ratio associated with ICR for patients older than age 80 years was 5.7 (95% confidence
interval, 1.8-18.0) versus 1.2 (95% confidence interval, 0.7-2.1) for younger patients.
Conclusions: This is the first study to suggest that ICR in patients with mostly arterial grafts is not associated
with decreased survival perioperatively and at midterm in patients younger than age 80 years. Arterial grafting,
because of longevity, may balance survival between complete revascularization and ICR. (J Thorac Cardiovasc
Surg 2014;147:75-84)The concept of complete revascularization (CR) in coronary
artery bypass graft (CABG) surgery portending to improved
patient outcomes was first espoused by McNeer and col-
leagues in 1974.1 This gold standard may not be applicable
today because data suggesting the benefits of CR included
young, stable patients, first-time procedures, and predomi-
nantly vein grafting.1 Newer studies are needed to evaluate
contemporary CABG surgery, including use of total ar-
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The Journal of Thoracic and Cprocedures in older, sicker patients. The goal of our study
was to determine if there was a survival advantage of
completely revascularized patients compared with ICR in
a patient cohort with predominantly (98%) arterial grafting.
We hypothesized that the long-term advantage of arterial
grafts would potentially counteract the reduced survival of
ICR in an all-comer group of CABG patients.
METHODS
From July 2003, to October 2012, total arterial grafting was performed
where possible in all patients by 1 surgeon at a high volume academic ter-
tiary care center. Patients were divided into 2 groups: Those in whom revas-
cularization was complete and those in whom it was not.
All patients were entered into the Alberta Provincial Program for
Outcome Assessment in Coronary Heart Disease study,2 a prospective
data collection initiative in the province of Alberta, Canada, since 1995. Pa-
tients are enrolled at initial cardiac catheterization and are followed to
assess long-term survival and repeat revascularization with percutaneous
coronary intervention (PCI) or CABG. Mortality is verified by linkage to
Alberta Vital Statistics. All study patients were also entered into a prospec-
tive surgical database, recording patient demographics and relevant surgi-
cal data. This study was approved by our institution’s research ethics board.
Angiogram and operative reports, and office charts of each patient were
independently reviewed by both an interventional cardiologist and a car-
diac surgeon to determine completeness of the revascularization. Revascu-
larization was considered complete when all diseased arterial territories inardiovascular Surgery c Volume 147, Number 1 75
Abbreviations and Acronyms
CABG ¼ coronary artery bypass graft
CIRC ¼ circumflex artery
CR ¼ complete revascularization
EuroSCORE ¼ European System for Cardiac
Operative Risk Evaluation
FFR ¼ fractional-flow reserve
ICR ¼ incomplete revascularization
IMA ¼ internal mammary artery
LAD ¼ left anterior descending
PCI ¼ percutaneous coronary intervention
RCA ¼ right coronary artery
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Dleft anterior descending (LAD) artery, circumflex artery (CIRC), and right
coronary artery (RCA) regions, with70% stenosis—or50% in the left
main artery—received at least 1 bypass graft for coronary arteries
measuring>1 mm in diameter. Left main revascularization was considered
complete if grafts were placed to the LAD and CIRC.
Five categories of reasons for incomplete revascularization (ICR) were
obtained from operative reports: small vessel (<1 mm diameter), diffuse
disease precluding healthy anastomosis, coronary artery inaccessible for
grafting (location in the atrioventricular groove), infarcted territory (aki-
netic wall, thinned segment, or nonviable myocardium), technical prob-
lems (adhesions in reoperative surgery, high-risk or porcelain aorta
needing off-pump procedure).
Surgery Details
All operations were performed off- or on-pump. For on-pump proce-
dures, we used intermittent antegrade blood cardioplegia and systemic
hypothermia to 32C. Off-pump CABG was performed with the
Octopus stabilizing device (Medtronic, Inc, Minneapolis, Minn). Inter-
nal mammary artery (IMA) conduits were harvested in a skeletonized
manner, with the left IMA anastomosed to the LAD and the right
IMA to either the CIRC or RCA. IMAs were used mostly as in-situ
grafts and were wrapped in papaverine-soaked gauze after harvesting.
High spinal anesthesia (local anesthetic and opioid) supplemented by
light general anesthesia was used. Intraoperative transesophageal echo-
cardiography was used except where contraindicated. Long-acting ni-
trates were used postoperatively for 6 weeks in only patients with
radial artery grafts.
Statistical Analysis Methods
Descriptive analysis. Descriptive statistics (Table 1) for categorical
variables and the means  standard deviation for normally distributed
continuous variables and the median and interquartile range (IQR) for
non-normally distributed variables were provided for all patients. Compar-
isons of baseline variables were made between patients who experienced
ICR and those who did not, only in patients with multivessel disease
(single-vessel disease patients by virtue of their inability to be incompletely
revascularized were excluded) (Table 2). Comparisons were made using
the Fisher exact test for categorical variables and the t test (for normally
distributed) or Wilcoxon signed rank tests (for non-normally distributed)
continuous variables.
Regression modeling strategy for both logistic and pro-
portional hazards regression. Initially we used individual
regression models for each variable in Table 1 to examine if they were sig-
nificant predictors of outcome. The functional form for continuous vari-
ables was examined using residuals analysis and if nonlinearity was
detected, suitable transformations were used or the variable was76 The Journal of Thoracic and Cardiovascular Surgecategorized using appropriate cut-points to aid interpretation of the model.
Next we entered each variable in Table 1 into a regression model, including
the ICR variable to assess for confounding. In the event of evidence of con-
founding we examined the possibility of an interaction between ICR and
that variable. All variables significant at P<.2 in the individual regression,
interactions significant at P<.20 and variables that appeared to be con-
founding were entered into a multivariable logistic regression model.
The possibility of collinearity was examined between predictor variables;
the inclusion of highly correlated predictor variables that might cause insta-
bility of the model was avoided. To avoid overfitting, we reduced the model
by excluding nonsignificant variables (starting with the largest P value),
provided that this did not change the estimate of the primary predictor var-
iable, ICR (ie, the excluded variable did not contribute to confounding).
This process continued until the appropriate number of degrees of freedom
in the model was retained (n/10) where n is the number deaths in each
model.
Logistic regression was used to assess operative mortality, with the ef-
fect of univariate predictors presented as odds ratios (ORs) with 95% con-
fidence intervals (CIs) and estimates of 30-day mortality for each level of
the variable. The multivariable model was presented as ORs and adjusted
30-day morality rates were estimated using predictive margins.
Midterm survival was estimated in the operative-survivor patient popu-
lation, using proportional hazards regression. Out-of-province patients not
available for follow-up were excluded. The assumption for proportional
hazards was examined using Schoenfeld residuals.3RESULTS
Study Population
From July 18, 2003, to February 2, 2013, 1000 consecu-
tive patients underwent CABG surgery with 98% (2922 out
of 2981) arterial grafts. Excluding 59 patients (6%) with
single vessel coronary artery disease, 73% (686 out of
941) of patients had bilateral IMA grafts. The majority of
patients had triple vessel disease (60%; 600 out of 1000)
and 34% had double vessel disease (341 out of 1000). Graft
conduits consisted of 70% IMAs, 28% radial arteries, 2%
venous grafts, and 4 grafts were inferior-epigastric arteries.
Eighty-six percent of the ICR group (120 out of 140
patients) had triple vessel disease. Demographics of the
patient groups are shown in Table 1. Patients with ICR
were older, had higher European System for Cardiac Oper-
ative Risk Evaluation (EuroSCORE) category, experienced
more reoperative CABG, underwent off-pump procedures,
and were less likely to have normal ejection fraction.ICR Versus CR
CR was achieved in 801 out of 941 patients (85%) with
multivessel disease and ICR occurred in 140 patients
(15%). Significant predictors of ICR are presented in
Table 2. The ICR group had less bilateral IMA grafting,
more off-pump procedures, higher logistic EuroSCORE
category, was more likely to have collaterals, was older,
more patients with ejection fraction<30%, fewer outpa-
tients, and more likely to undergo reoperative surgery.
The numbers for very low ejection fraction and reoperation
were small in both groups. No other cardiac risk factors or
comorbidities were associated with ICR.ry c January 2014
TABLE 1. Baseline characteristics of the study population of 1000 patients; 801 with complete revascularization 140 with incomplete
revascularization and 59 with single vessel disease
All patients (N ¼ 1000)* CR (n ¼ 801) ICR (n ¼ 140) P valuey
Bilateral internal mammary artery grafts 686 (68.6) 626 (78.2) 60 (42.9) <.001
Off-pump coronary artery bypass graft 387 (38.7) 283 (35.3) 64 (45.7) .023
EuroSCORE (median [IQR]) 2.9 (1.5-6.2) 2.7 (1.5-5.9) 5.0 (2.7-10.2) <.001
Collaterals 628 (62.9) 489 (61.2) 116 (82.9) <.001
Demographics
Age, mean  standard deviationz 64.9  10.4 64.4  10.3 68.9  9.4 <.001
Male 779 (77.9) 624 (77.9) 112 (80.0) .657
Outpatient 435 (43.5) 370 (46.2) 44 (31.4) .004
Inpatient 454 (45.4) 345 (43.1) 76 (54.3) .138
Emergent 111 (11.1) 86 (10.7) 20 (14.3) .279
Comorbidities
Hypertension 690 (69.0) 549 (68.5) 102 (72.9) .323
Hypercholesterolemia 697 (69.7) 555 (69.3) 102 (72.9) .426
Diabetes 344 (34.4) 279 (34.8) 53 (37.9) .503
Ever smoked 587 (58.7) 470 (58.7) 87 (62.1) .457
Active smoker 208 (20.8) 171 (21.3) 31 (22.1) .824
Ejection fraction>50% 66 (6.6) 45 (5.6) 21 (15.0) <.001
Ejection fraction 30%-50% 228 (22.8) 182 (22.7) 37 (26.4) .455
Ejection fraction<30% 706 (70.6) 574 (71.7) 82 (58.6) .177
Body mass index 30 338 (33.8) 275 (34.3) 45 (32.1) .630
Chronic obstructive pulmonary disorder 131 (13.1) 103 (12.9) 24 (17.1) .180
Cerebrovascular disease 101 (10.1) 79 (9.9) 18 (12.9) .292
Peripheral vascular disease 105 (10.5) 87 (10.9) 17 (12.1) .661
Renal diseasex 35 (3.5) 27 (3.4) 7 (5.0) .328
Reoperative coronary artery bypass graft 37 (3.7) 23 (2.9) 10 (7.1) .021
Data are presented as n (%) unless otherwise indicated. CR, Complete revascularization; EuroSCORE, European System for Cardiac Operative Risk Evaluation; IQR, interquar-
tile range; ICR, incomplete revascularization. *Includes 59 single vessel disease patients. yComparing ICR patients (n ¼ 140) to CR patients (n ¼ 801). zRange (29-96 years).
xCreatinine>200 mg/dL.
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Overall operative mortality was 3.8%. In ICR patients,
30-day mortality was 8.6% compared with 3.2% in patients
with complete revascularization (P ¼ .008).
Examination of the continuous variables age and logis-
tic EuroSCORE categories revealed substantial nonline-
arity in the prediction of mortality. Although log
transformation of the logistic EuroSCORE category and
a quadratic form for age described this nonlinearity
well, we decided to categorize the variables to ease inter-
pretation. Age categories were<65 years, 65 to 80 years,
and 80 years. For EuroSCORE, there was substantial
heterogeneity in the highest risk category (EuroSCORE
>6); therefore we subdivided this category into 6 to
9.99, 10 to 19.99, and 20.
Baseline factors associated with 30-day mortality are
shown in Table 3. Most were also confounders of the rela-
tionship between ICR and operative mortality and were
considered eligible for entry into the multivariate logistic
regression model. Off-pump procedure history and sex
were potential confounding variables and were therefore
entered into the multivariable model.
In this full model, the effect of ICR was not significant
(OR, 1.82; 95% CI, 0.78-4.22; P ¼ .168). In the reducedThe Journal of Thoracic and Cmodel (Table 3), containing only ICR, EuroSCORE cate-
gory, and urgency, the estimated OR was 1.73 (95% CI,
0.80-3.77; P ¼ .166). Adjusted operative mortality was
5.6% (95% CI, 2.7-8.5) for ICR patients and 3.6% (95%
CI, 2.3-4.6; P ¼ .166) for CR patients, indicating that after
controlling for EuroSCORE category and urgency the effect
of ICR on 30-day mortality, although higher than that for
CR patients, was not significantly different. For the 65 oc-
togenarians (1 patient aged 96 years), there was no differ-
ence in operative mortality due to ICR (for ICR: 9.5%;
95% CI, 1.2-30.3 and for CR: 6.8%; 95% CI, 1.4-18.6;
P ¼ .655), even though the 37 octogenarians with off-
pump CABG history had a significantly higher rate of
ICR compared with the non-octogenarians. (48.7% for
age 80 years; 95% CI, 31.9-65.6 compared with 10.7%
for age<80 years; 95% CI, 2.3-28.2; P<.001).
Midterm Follow-up
Thirty-eight patients who died during the 30-day postop-
erative period and 62 patients who were out-of-province
were excluded from the midterm follow-up, leaving a total
of 841 patients for follow-up (723 with CR and 118 with
ICR). The median follow-up time was 56 months. ICR
was a significant predictor of midterm mortality (hazardardiovascular Surgery c Volume 147, Number 1 77
TABLE 2. Significant predictors (P < .15) of incomplete
revascularization
Variable % ICR (95% CI) P value
Overall 14.9 (12.7-17.3)
Off-pump .023
Yes 18.4 (14.5-22.9)
No 12.8 (10.2-15.8)
Bilateral internal mammary artery grafts <.001
Yes 8.8 (6.7-11.1)
No 31.4 (25.7-37.5)
EuroSCORE <.001
0-2.99 8.7 (6.3-11.6)
3-5.99 18.6 (13.6-24.5)
6 23.4 (18.3-29.1)
Age <.001
<65 10.6 (7.8-14.0)
65-79 16.5 (13.1-20.3)
80 32.3 (21.1-45.1)
Urgency .004
Elective 10.6 (7.8-14.0)
Urgent in 18.1 (14.5-22.1)
Emergency 18.9 (11.9-27.6)
Ejection fraction <.001
<30 31.8 (20.9-44.4)
30-50 16.9 (12.2-22.5)
>50 12.5 (10.1-15.3)
Collaterals <.001
Yes 19.2 (16.1-22.5)
No 7.2 (4.7-10.6)
Reoperative CABG .021
Yes 30.3 (15.6-48.7)
No 14.3 (12.2-16.8)
CI, Confidence interval; EuroSCORE, European System for Cardiac Operative Risk
Evaluation; CABG, coronary artery bypass graft; ICR, incomplete revascularization.
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Dratio [HR], 2.0; 95% CI, 1.3-3.3). Unadjusted overall sur-
vival curves are presented in Figure 1, A. Examination of
the linearity continuous variables revealed that different
cut-points were more appropriate when predicting midterm
mortality. Thus age had 2 categories (<80 and 80 years)
and EuroSCORE had 3 categories (0-2.99, 3-5.99, and
6). (see Table 4.) There was evidence against the propor-
tional hazards assumption for urgency; therefore, this vari-
able was not included in the model, but used for
stratification. Only 2 variables were confounding factors:
age>80 years and EuroSCORE. Interactions between these
2 variables and ICR were examined and the interaction with
EuroSCORE was not significant (P ¼ .240), whereas the
interaction with age was significant (P ¼ .072). The unad-
justed HR was 4.7 (95% CI, 1.5-14.4) for patients older
than age 80 years and 1.5 (95% CI, 0.9-2.7) for patients
younger than age 80 years in a model that contained only
the interaction between age and ICR. Therefore the
age 3 ICR interaction along with the predictors significant
at P<.2 were entered into the multivariable proportional
hazards model, stratified by urgency due to the78 The Journal of Thoracic and Cardiovascular Surgenonproportional hazards for this variable. Chronic obstruc-
tive pulmonary disease, renal disease, cerebrovascular dis-
ease, peripheral vascular disease, and diabetes were all
combined into a single variable of a comorbid condition.
The final model (Table 5) included the age 3 ICR interac-
tion (P¼ .017), comorbid conditions (P¼ .017), the 3 cate-
gory EuroSCORE (P<.001), and sex (P¼ .25) because this
was a confounding factor. The adjusted HR associated with
ICR for patients aged80 years was 5.7 (95%CI, 1.8-17.7)
indicating a higher risk of mortality due to ICR in older
patients. The estimated adjusted HR for patients younger
than age 80 years was 1.2 (95% CI, 0.7-2.1). The unad-
justed 5-year survival rate for patients younger than age
80 years was 90.9% for CR patients and 86.0% and for
ICR patients. For patients aged 80 years the 5-year sur-
vival rate was 77.7% for CR patients and 56.4% for ICR
patients. (Figure 1, B). Three factors significantly predicted
decreased long-term survival in the octogenarians and older
patients: ICR (P ¼ .006), higher logistic EuroSCORE cate-
gory (P¼ .006), and male sex (P¼ .029). When included in
the same regression model all 3 variables were simulta-
neously significant (P ¼ .029 for EuroSCORE, P ¼ .032
for ICR, and P ¼ .021 for men.) This indicates that even
controlling for fragility using EuroSCORE category, the
HR for ICR was 2.9 (95% CI, 1.1-7.7) and HR for male
sex was 4.4 (95% CI, 1.2-15.4).
Examination of these unadjusted survivor functions indi-
cates that midterm survival in ICR patients younger than
age 80 years was not statistically significantly different
from CR patients, either before (P¼ .141) or after adjusting
for other predictive factors (P ¼ .544).
Other Outcomes
Therewas no difference between ICR and CR patients for
recurrence of angina (6.4%; P ¼ .99), myocardial infarc-
tion (1.8%; P ¼ 1.0), and postoperative angiography either
for any reason (15.5%; P ¼ .787) or symptom-directed
(13.3%; P ¼ 1.00). Repeat revascularization procedures
with either PCI or CABG were also similar (0.7%;
P ¼ .267).
Reasons for ICR
Reasons for ICR in 140 patients included small vessel
<1 mm in 64% (n ¼ 92), diffuse disease in 17%
(n¼ 24), inaccessible location in 14% (n¼ 20), infarct ter-
ritory in 22% (n ¼ 31), technical reasons in 9% (n ¼ 13),
and multiple reasons in 25% (n ¼ 36). The RCA was the
most common artery not bypassed (52%), with 48% for
the CIRC. A diseased LAD territory was bypassed in all pa-
tients at this or at a previous surgery. The most common rea-
sons for not bypassing the CIRC was small vessel and
location, whereas reasons for not grafting the RCA were
small vessel and diffuse disease. For 138 of 140 patients
(99%) 1 territory of 3 was not bypassed; in 2 patientsry c January 2014
TABLE 3. Predictors of operative mortality
Variable
Single predictor variable analysis Multivariable model
% Operative mortality (95% CI) OR (95% CI) P value OR (95% CI) P value*
Constant 0.002 (0.00-0.01) <.001
Incomplete revascularization .008 1.73 (0.80-3.77) .166
Yes 3.2 (2.0-4.5) 2.8 (1.4-5.7)
No 8.6 (3.9-13.2) 1
EuroSCOREy <.001 1 <.001
<3 0.4 (0.05-1.5) 1
3-5.99 3.3 (0.9-5.6) 7.9 (1.6-38.6) 5.4 (1.1-27.1)
6-9.99 6.8 (2.3-11.4) 17.3 (3.6-82.7) 10.2 (2.0-50.6)
10-19.99 7.8 (3.1-15.4) 19.9 (4.1-97.5) 8.9 (1.7-47.8)
20 31.1 (17.6-44.6) 106 (23.2-490) 42.2 (8.0-223.5)
Urgencyy <.001 1 .03
Elective 0.7 (0.0-1.5) 1
Urgent in 4.0 (2.2-5.9) 5.8 (1.7-19.8) 3.2 (0.88-11.4)
Emergency 17.0 (9.8-24.1) 28.0 (8.1-97.2) 5.6 (1.4-21.9)
Bilateral internal mammary artery graftsy .017
Yes 6.7 (3.6-9.7) 0.44 (0.23-0.85)
No 3.1 (1.8-4.4) 1
Agey, y .061
<65 2.5 (1.1-4.0) 1
65-80 5.0 (2.9-7.0) 2.0 (1.0-4.2)
>80 7.7 (1.2-14.2) 3.2 (1.1-9.5)
Hypertension .03
Yes 4.9 (3.3-6.6) 2.4 (1.0-5.9)
No 2.1 (0.1-3.7)
Ejection fractiony .021
<30 10.6 (3.2-18.0) 1
<30-50 4.6 (1.8-7.3) 0.4 (0.2-1.1)
>50 3.2 (1.9-4.5) 0.3 (0.1-0.7)
Cerebrovascular disease .013
Yes 8.2 (2.7-13.7) 2.4 (1.1-5.5)
No 3.6 (2.3-4.8)
Peripheral vascular disease .145
Yes 6.7 (1.9-11.5) 1.9 (0.8-4.4)
No 3.7 (2.4-5.0)
Renal disease
Yes 14.6 (2.8-26.6) 4.6 (1.7-12.6) .003
No 3.6 (2.4-4.9)
Reoperative CABGy
Yes 15.2 (2.9-27.4) 4.7 (1.7-13.0) .003
No 3.6 (2.4-4.9)
CI, Confidence interval; OR, odds ratio; EuroSCORE, European System for Cardiac Operative Risk Evaluation; CABG, coronary artery bypass graft. *Likelihood ratio statistic.
ySignificant predictors of incomplete revascularization.
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onary arteries were too small in 1 patient and both diffusely
diseased and small in the second.
DISCUSSION
In this large contemporary series of 1000 CABG patients
with 98% arterial grafts, we have shown that after adjusting
for factors affecting operative mortality and midterm sur-
vival, there is no evidence that ICR decreases survival peri-
operatively in all patients and at midterm in patients
younger than age 80 years. Ours is the first study to evaluateThe Journal of Thoracic and Coutcomes from ICR in a cohort of patients with extensive
(98%) arterial grafting. Midterm follow-up analysis yielded
a dichotomous result: for patients younger than age 80 years
ICR did not affect survival before or after adjusting for 11
significant predictors, even though 1 of these (EuroSCORE)
was a confounding variable. There was, however, a signifi-
cant effect of lCR on reduced midterm survival in patients
aged 80 years (7% of the overall cohort). Other studies
have shown age conundrums: Girerd and colleagues4 found
that patients aged<60 years had increased mortality with
ICR but not in patients aged >60 years. Three articlesardiovascular Surgery c Volume 147, Number 1 79
FIGURE 1. A, Unadjusted overall survival rates by complete and incomplete revasculariztion. B, Unadjusted Kaplan-Meier survival curves stratified by
age<80 years (n ¼ 788) and age 80 years (n ¼ 53).
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and colleagues5 found no difference in survival in octoge-
narians with ICR whereas Aziz and colleagues6 found
18% decline and Kozower and colleagues7 found 10%
reduced 8-year survival in octogenarians with ICR. For
the 53 patients aged 80 years in this series who survived
the operation, ICR carries an almost 6-fold risk of dying
but this may be sample-specific. This finding of reduced
survival in octogenarians with ICR is not explainable
within the data/scope of our study but deserves careful80 The Journal of Thoracic and Cardiovascular Surgeconsideration regarding its validity and/or meaningfulness.
Given that operative survival was not affected by ICR in this
age group, surgeons may wisely opt for early survival rather
than subject frail elderly patients to a CR operation of
greater risk; for example a difficult-to-graft lateral wall
target performed off-pump. Although well-selected elderly
patients undergoing CABG have good outcomes, an objec-
tive assessment of frailty has been found to be associated
with increased risk for morbidity and mortality after cardiac
surgery.8,9ry c January 2014
TABLE 4. Individual predictors of midterm mortality, single
predictor variable analysis
Variable Hazard ratio P value 95% CI
Incomplete revascularization 2.0 .003 1.3-3.3
Off-pump 1.4 .151 0.9-2.4
Male 0.5 .004 0.4-0.8
Chronic obstructive pulmonary
disease
2.0 .006 1.2-3.2
Renal disease 3.8 <.001 1.9-7.6
Peripheral vascular disease 2.5 <.001 1.6-4.2
Re-do coronary artery bypass graft 2.0 .090 0.9-4.2
Cardiovascular disease 2.2 .002 1.3-3.7
Diabetes mellitus 1.5 .049 1.0-2.3
Bilateral internal mammary artery
grafts
0.8 .176 0.5-1.1
Age>80 y* 2.8 .001 1.6-5.0
EuroSCORE*
3-5.99 1.9 <.001 1.1-3.3
6 4.0 2.5-6.4
CI, Confidence interval; EuroSCORE, European System for Cardiac Operative Risk
Evaluation. *Variable was also a confounding factor. Estimates for urgency were not
included because there was evidence against the proportional hazards assumption for
urgency.
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have included patients in which the majority of grafts
were venous. Poorer outcomes with ICR in such popula-
tions may not be due to the ICR in and of itself but rather
due to relatively early occlusion of venous conduits. Early
postoperative vein graft occlusion has not changed in 4 de-
cades: at<3 weeks postoperatively in the study by FitzGib-
bon and colleagues10 of 5065 venous grafts performed from
1969 to 1994, vein graft occlusion was 12%, similar to the
more contemporary study from Kim and colleagues11
wherein 7-day vein graft occlusion was 11.8%. One-year
graft occlusion rates have also stayed the same since the
study by FitzGibbons and colleagues10: 24% compared
with the 1-year vein graft occlusion in the Prevent IV trial12
of 25.7%. This rapid attrition of vein grafts would convert a
patient with single vessel disease (1 territory not bypassed)
at the time of CABG to double vessel disease in 12% of pa-
tients at early postoperation and in 24% to 26% of patientsTABLE 5. Multivariable proportional hazards regression model
predicting midterm survival in patients who survived the
postoperative period, stratified by urgency
Variable Hazard ratio P value 95% CI
Incomplete revascularization
Age>80 y 5.7 .003 1.8-17.7
Age<80 y 1.2 .544 0.7-2.1
Comorbid condition 1.74 .017 1.10-2.73
EuroSCORE <.001
3-5.99 1.71 0.96-3.04
6 3.25 1.84-5.73
Male 0.71 .125 0.46-1.10
CI, Confidence interval; EuroSCORE, European System for Cardiac Operative Risk
Evaluation.
The Journal of Thoracic and Cat 1 year and could well explain the poorer survival of pa-
tients with ICR. The use of more arterial conduit known
to last longer could therefore mitigate the effect of ICR.
Other Studies of CR and Arterial Grafting
The literature on ICR is difficult to interpret due to lack of
a universal definition; varying lengths of follow-up;
differing amounts of arterial and venous grafting; studies
including just PCI, just patients undergoing CABG, or a
combination of both; and studies including only specific
subgroups such as patients with diabetes and octogenarians.
Hence there is no consistent negative correlation between
ICR and survival; studies showing reduced survival with
ICR include the 10-year follow-up of the Medicine, Angio-
plasty, or Surgery Study for Patients Undergoing PCI
(MASS II),13 the Bypass Angioplasty Revascularization
Investigation 2 Diabetes trial in persons with diabetes,14
the 4-year SYNTAX trial results (including both random-
ized and registry patients),15 patients younger than age 60
years by Girerd and colleagues,4 studies in octogenarians,6,7
a study by Synnergren and colleagues16 in patients with 2 of
3 territories missed, and a 5-year follow-up study by Kleisli
and colleagues.17 Studies showing the opposing view—no
difference in survival between ICR and CR groups—
include as many studies and some even in similar patient
subgroups: the 10-year follow-up of the MASS II trial for
patients undergoing CABG11; a study of octogenarians by
Mohammadi and colleagues5; a study with left internal
thoracic artery to LAD in only 75% to 77% of patients
by Kim and colleagues11; McNeer and colleagues’ 1974
study1 of patients with all vein grafts; a study of patients
older than age 60 years by Girerd and colleagues4; a study
by Sarno and colleagues,18 including patients undergoing
PCI with less complex disease; a study by Rastan and col-
leagues19 with no difference at 1 and 5 years follow-up;
the SYNTAX trial (randomized patients) at 1 year20; a study
by Synnergren and colleagues16 for no difference if 1 of 3
territories missed; and the Bypass Angioplasty Revascular-
ization Investigation trial, which also noticed that multiple
grafting resulted in worse survival.21
Other investigators have assessed the effects of ICR in
patients with multiple arterial grafts, and similar to our
own findings, found no difference in survival between
CR and ICR: MASS II with 1 IMA in 92%, 1 IMA with
radial artery grafts in 36% and epigastric artery grafts in
10%.13 Rastan and colleagues’ study19 with 21.9% total
arterial grafting in the CR group and 32.2% in the ICR
group found that arterial revascularization was protective
for decreased mortality, and Kleisli and colleagues’ study17
showed that use of the right IMA (22.6%) and radial artery
(58.7%) correlated with improved survival at a mean of
5 years (HR, 0.51 for right IMA use and 0.49 for radial ar-
tery use). Hayward and colleagues22 showed that use of
arterial grafts for lesions (largely severe) in the rightardiovascular Surgery c Volume 147, Number 1 81
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vessel disease whereas bypassed moderate lesions with
saphenous vein caused greater native lesion progression
to severe 40% versus 14% of the time if not bypassed.
Arterial grafting especially with IMAs prevents native dis-
ease progression.23 Because a randomized controlled trial
comparing patients with CR versus ICR is not possible, ev-
idence for rationale of the CR dogma is dependent on
retrospective observational studies. Our study of almost
pure arterial grafting eliminates 1 important variable:
The venous graft.
Early theories of what were appropriate revasculariza-
tions and hence the definition of ICR must by necessity,
change. Before the advent of angioplasty,24 coronary ar-
teries with 50% stenosis were routinely bypassed to avoid
reoperation for disease progression. Venous conduits offer
almost no resistance to flow whereas competitive flow is a
significant factor when using arterial conduits.25 Also, use
of fractional-flow reserve (FFR) has demonstrated that
many lesions26 are not hemodynamically significant. In
the ongoing Evaluation of Xience Prime Everolimus
Eluting Stent System (EECSS) or Xience V EECSS Versus
Coronary Artery Bypass Surgery for Effectiveness of Left
Main Revascularization (EXCEL) trial27 randomizing low
SYNTAX score patients with left main stenosis to PCI or
CABG, CR for the PCI arm favors addressing 70% nar-
rowed coronary arteries, whereas for the CABG arm it is
50% stenosis. Opinion as to the level of significant stenosis
appears to be changing, but should change similarly for both
PCI and CABG. G€ossl and colleagues28 proposed a new
definition for both PCI and CABG: CR complete anatomic
(>50% stenosis;>1.5 mm coronary arteries), ICR anatomic
but functionally adequate (FFR>70%), and ICR anatom-
ical and functionally inadequate (FFR70). This third cate-
gory is probably significant for survival; the authors state:
‘‘.CR based on anatomic criteria alone may soon become
obsolete, emphasizing physiology driven coronary inter-
ventions.’’28 There is even evidence to show that ‘‘over-
grafting’’ may be detrimental.21 However unless FFR
testing becomes routine for pre-revascularization assess-
ment at coronary angiography, perhaps what is simplest is
best: the definition of CR used in our study is the same as
the very first used by McNeer and colleagues1 in 1974: a
revascularization by ‘‘territory’’; that is, 1 bypass for each
territory that has a 70% stenosis in a major branch.
Limitations
Limitations of our study include the relatively small
number of the ICR group, the small number of octogenar-
ians (and older) and the number of factors found to signifi-
cantly influence survival. This real-world, single-center
study evaluating total arterial grafting performed by a single
operator may be advantageous because it provides consis-
tent techniques, skills, and decision making but at the82 The Journal of Thoracic and Cardiovascular Surgesame time may not be applicable to other centers. Ongoing
use of evidence-based medications for secondary preven-
tion, which is known to affect outcome, was not evaluated
in this study. Finally, we evaluated outcomes out to 4.5 years
but longer follow-up may be required to better evaluate the
consequences of ICR, especially because the advantage of
arterial grafts may last decades.CONCLUSIONS
Contrary to current beliefs regarding completeness of
revascularization, we have demonstrated that ICR in this
unique series of all-comer CABG with 98% arterial grafts
is not associated with decreased survival perioperatively
and at midterm in patients younger than age 80 years. How-
ever many factors affect survival and may act synergisti-
cally or independently. Use of arterial grafts minimizes
the adverse effects of not grafting the third region.
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Dr Philip A. Hayward (Melbourne, Australia). I’d like to
thank the American Association for Thoracic Surgery Committee
for the invitation to discuss this work and also thank Dr Kieser for
supplying me with a draft of the manuscript in a timely fashion.
Dr Kieser, you are to be congratulated on an important study.
You’ve done a sophisticated analysis of your own coronary prac-
tice, and your commitment to arterial grafting and to completeness
of revascularization is impressive.The Journal of Thoracic and CYou state as a limitation that this is a single-surgeon experi-
ence, but in this context this may be 1 of the merits of the study
because it allows us to really tease out the effect of incomplete
revascularization. Other series published can be pools of patients
done by different surgeons, with varying thresholds for grafting
small or poor targets, and it is difficult to tease out the effect
of incomplete revascularization when there have been 2 different
revascularization strategies and thresholds. You have a unifor-
mity of your threshold for revascularization—the same eyes,
the same hands, the same threshold—I think that’s why your
study is unique.
Fractional-flow reserve (FFR) is redefining what we think
needs revascularization now. It’s all about physiology, not anat-
omy, we know that from percutaneous intervention and the
Fractional Flow Reserve versus Angiography for Multivessel
Evaluation study. FFR depends on the volume of distal ante-
grade flow, not just the stenosis. Vessels that are small or
running into scar or that are well collateralized do not have sig-
nificant FFR. About 87% of the vessels you left fall into this
category. I suggest that really your ‘‘incomplete revasculariza-
tion’’ group was in fact functionally completely revascularized
for the most part, and the vessels that you left alone really
were functionally insignificant. And that’s probably why you’ve
not shown any effect on survival from your ‘‘incomplete revas-
cularization’’ and that’s reflected in the lack of a difference in
angina, myocardial infarction, or percutaneous coronary inter-
vention thereafter.
You say that your findings differ from other authors because you
used arterial grafts rather than vein grafts and that you therefore
avoided early vein graft failure. But, of course, you also avoid
the progression of native vessel disease that’s seen primarily after
vein grafts, and it is this progression that can damage the collater-
alization that had been providing protection from the effects of
incomplete revascularization. An all-arterial graft population has
been shown to produce less native vessel disease progression, so
perhaps the collaterals are better preserved and hence your
different findings.
I would like to pose 2 questions: The surprise finding clearly is
the difference in the long-term outcome in the octogenarians who
had incomplete revascularization. Do you really think this is a
different effect of incomplete coronary revascularization in older
people, or is there another factor here—a frailty factor—where
really this was a different pool of frail elderly people where you
lowered your threshold for leaving targets alone, such that really
their poorer survival comes from their frailty rather than the fact
that you decided to leave 1 target?
The second question follows from that. You told us that
incomplete revascularization didn’t affect in-hospital mortality
overall, but was that also true for the octogenarians whose
long-term outcome you say is poorer with incomplete revascu-
larization? Perhaps their long-term outcome is just a reflection
of a turbulent perioperative period. I think that shorter-term
outcome data might influence most surgeons’ practice more
than the long-term survival, because many of us faced with frail
octogenarians are really focused on getting them out of the hos-
pital intact and we tend to lower our horizons. If I’m
faced with that frail octogenarian patient and I want to get
him or her safely through, does complete or incompleteardiovascular Surgery c Volume 147, Number 1 83
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matters in the long term?
Dr Teresa Kieser (Calgary, Alberta, Canada). Your point
regarding FFR is very well taken. Rastan and Fred Mohr had an
article in Circulation in 2009 that spoke to this. They didn’t say
the reason was FFR, but they spoke about vessels that were within
scar, for example. So it didn’t matter if you didn’t completely re-
vascularize them. I think your reason is correct, the FFR would be
insignificant. However, being the bilateral internal mammary ar-
tery graft fanatic that I am, I would still like to invoke the untimely
demise of the vein graft as a mechanism.
With respect to poorer survival coming from surgical frailty or not
wanting to put an older patient through the stress of surgery, I think
the reasons are 2-fold:Operatingon frail people does cause a surgeon
to possibly scale down the operative procedure. But experience has
taught me that when you operate on an 80-year old, everything has
to go correctly. They cannot tolerate the slightest complication the
way a younger patient would. The wheels easily fall off the wagon.84 The Journal of Thoracic and Cardiovascular SurgeIncomplete revascularization in an octogenarian patient perio-
peratively, you are right, we probably should have included this.
There were only 70 patients older than age 80 years, 53 were
incompletely revascularized, so that’s 76%.
The operative mortality was not different. There were 2 out of
23 incompletely revascularized patients who died, and 3 out of
47 of the completely revascularized patients died—a P value
that was insignificant. We looked at the cause of death of these 5
patients: 1 died from fulminant sepsis at another hospital, very
quickly; another had a massive stroke; another died of necrotic
bowel because he had embolized from a calcified aorta (we had
had to perform the procedure on him off-pump and he was a re-
do). The deaths of 2 patients of the 5 were probably due to graft-
ability issues or graft failure. Incomplete revascularization did not
make a difference in these patients. So the answer is if you can get
a patient—an 80-year-old—out of hospital alive and intact with
incomplete revascularization this is better.
Dr Hayward. That’s a great relief. Thank you.ry c January 2014
